Publications dans lesquelles il/elle collabore avec JUAN BUSTAMANTE MUNGUIRA (29)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study

    International Journal of Health Services, Vol. 52, Núm. 3, pp. 383-391

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  4. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

2021

  1. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials

    Frontiers in Medicine, Vol. 8

  2. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  3. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2019

  1. Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses

    Scientific Reports, Vol. 9, Núm. 1

  2. Near-infrared spectroscopy monitoring in cardiac and noncardiac surgery: Pairwise and network meta-analyses

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  3. Nosocomial vs. Community-acquired infective endocarditis in spain: Location, trends, clinical presentation, etiology, and survival in the 21st century

    Journal of Clinical Medicine, Vol. 8, Núm. 10

2018

  1. Correction of hyponatremia may be a treatment stratification biomarker: A two-stage systematic review and meta-analysis

    Journal of Clinical Medicine, Vol. 7, Núm. 9

  2. Evolution of the incidence, mortality, and cost of infective endocarditis in Spain between 1997 and 2014

    Journal of General Internal Medicine, Vol. 33, Núm. 10, pp. 1610-1613

  3. Impact of an ultraviolet air sterilizer on cardiac surgery patients, a randomized clinical trial

    Medicina Clinica, Vol. 151, Núm. 8, pp. 299-307

  4. Surgery for acute infective endocarditis: Epidemiological data from a Spanish nationwide hospital-based registry

    Interactive Cardiovascular and Thoracic Surgery, Vol. 27, Núm. 4, pp. 498-504

2017

  1. Procalcitonin and white blood cells, combined predictors of infection in cardiac surgery patients

    Journal of Surgical Research, Vol. 212, pp. 187-194

2016

  1. Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis

    Annals of Intensive Care, Vol. 6, Núm. 1

  2. Predicting cardiac surgery-associated acute kidney injury: The CRATE score

    Journal of Critical Care, Vol. 31, Núm. 1, pp. 130-138

  3. Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury

    Journal of Critical Care, Vol. 33, pp. 233-239